Next Article in Journal
Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Next Article in Special Issue
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
Previous Article in Journal
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Previous Article in Special Issue
Emerging Roles of ALK in Immunity and Insights for Immunotherapy
 
 
Article

Article Versions Notes

Cancers 2020, 12(7), 1903; https://doi.org/10.3390/cancers12071903
Action Date Notes Link
article pdf uploaded. 14 July 2020 15:31 CEST Version of Record https://www.mdpi.com/2072-6694/12/7/1903/pdf-vor
article supplementary file uploaded. 14 July 2020 15:31 CEST - https://www.mdpi.com/2072-6694/12/7/1903#supplementary
article pdf uploaded. 14 July 2020 15:31 CEST Updated version of record https://www.mdpi.com/2072-6694/12/7/1903/pdf-vor
article xml file uploaded 17 July 2020 14:24 CEST Original file -
article xml uploaded. 17 July 2020 14:24 CEST Update https://www.mdpi.com/2072-6694/12/7/1903/xml
article pdf uploaded. 17 July 2020 14:24 CEST Updated version of record https://www.mdpi.com/2072-6694/12/7/1903/pdf
article html file updated 17 July 2020 14:25 CEST Original file -
article html file updated 30 July 2020 16:15 CEST Update -
article html file updated 22 July 2022 00:04 CEST Update https://www.mdpi.com/2072-6694/12/7/1903/html
Back to TopTop